• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板活化因子所致低血压的机制

Mechanisms of hypotension produced by platelet-activating factor.

作者信息

Laurindo F R, Goldstein R E, Davenport N J, Ezra D, Feuerstein G Z

机构信息

Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799.

出版信息

J Appl Physiol (1985). 1989 Jun;66(6):2681-90. doi: 10.1152/jappl.1989.66.6.2681.

DOI:10.1152/jappl.1989.66.6.2681
PMID:2745330
Abstract

Platelet-activating factor (PAF) is a phospholipid mediator that induces cardiovascular collapse and release of the secondary mediator thromboxane A2 (TxA2). To clarify mechanisms involved in this collapse and, specifically, the relative contribution of left ventricular and right ventricular dysfunction, we studied 12 open-chest pigs. PAF infusion (0.04-0.28 nmol.kg-1.min-1) induced a 5- to 120-fold increase in pulmonary vascular resistance, a 75-98% fall in cardiac output, and systemic arterial hypotension. Right ventricular failure was indicated by chamber enlargement, decreased shortening, and increased right atrial pressures. In contrast, left ventricular dysfunction was accompanied by decreases in chamber dimensions and filling pressures that were unresponsive to volume expansion. U 46619 (a stable TxA2 analogue) and mechanical pulmonary artery constriction induced changes similar to PAF. In 11 additional closed-chest pigs, TxA2 blockade with indomethacin attenuated the PAF-induced rise in pulmonary vascular resistance, right ventricular dysfunction, and systemic hypotension. A specific TxA2 synthase inhibitor, OKY-046, also diminished hemodynamic effects of PAF in six other pigs. Tachyphylaxis was not observed in five pigs repeatedly given PAF. We conclude that acute right ventricular failure as the result of severe increase in pulmonary vascular resistance is the primary mechanism early in the course of PAF-induced shock in the pig. PAF-induced release of TxA2 may contribute significantly to these events.

摘要

血小板活化因子(PAF)是一种磷脂介质,可诱发心血管衰竭并释放次级介质血栓素A2(TxA2)。为了阐明参与这种衰竭的机制,特别是左心室和右心室功能障碍的相对作用,我们研究了12只开胸猪。输注PAF(0.04 - 0.28 nmol·kg⁻¹·min⁻¹)可使肺血管阻力增加5至120倍,心输出量下降75 - 98%,并导致体循环动脉低血压。右心室衰竭表现为心室扩大、缩短率降低和右心房压力升高。相比之下,左心室功能障碍则伴有心室尺寸和充盈压降低,且对容量扩张无反应。U 46619(一种稳定的TxA2类似物)和机械性肺动脉收缩引起的变化与PAF相似。在另外11只闭胸猪中,用吲哚美辛阻断TxA2可减轻PAF诱导的肺血管阻力升高、右心室功能障碍和体循环低血压。一种特异性TxA2合酶抑制剂OKY - 046在另外6只猪中也减弱了PAF的血流动力学效应。在5只反复给予PAF的猪中未观察到快速耐受性。我们得出结论,在猪中,PAF诱导的休克过程早期,肺血管阻力严重增加导致的急性右心室衰竭是主要机制。PAF诱导的TxA2释放可能对这些事件有显著贡献。

相似文献

1
Mechanisms of hypotension produced by platelet-activating factor.血小板活化因子所致低血压的机制
J Appl Physiol (1985). 1989 Jun;66(6):2681-90. doi: 10.1152/jappl.1989.66.6.2681.
2
Influence of thromboxane A2 receptor antagonism on pulmonary vasoconstrictor responses.血栓素A2受体拮抗作用对肺血管收缩反应的影响。
Pediatr Res. 1989 Sep;26(3):175-9. doi: 10.1203/00006450-198909000-00002.
3
In vivo enhancement of platelet activating factor-induced prostacyclin production by OKY-046, a selective inhibitor of thromboxane A2 synthase.血栓素A2合酶选择性抑制剂OKY-046对血小板活化因子诱导的前列环素生成的体内增强作用。
J Cardiovasc Pharmacol. 1991 Apr;17(4):641-6. doi: 10.1097/00005344-199104000-00018.
4
Cardiovascular effects of platelet-activating factor.血小板活化因子的心血管效应
Lipids. 1991 Dec;26(12):1250-6. doi: 10.1007/BF02536542.
5
Pulmonary vascular response to platelet-activating factor in conscious sheep.清醒绵羊对血小板活化因子的肺血管反应。
Am J Physiol. 1988 Sep;255(3 Pt 2):H434-40. doi: 10.1152/ajpheart.1988.255.3.H434.
6
Inhibitory action of OKY-O46.HCl, a specific TXA2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness of guinea pigs: role of TXA2 in development of PAF-induced nonspecific airway hyperresponsiveness.
Jpn J Pharmacol. 1990 Apr;52(4):621-30. doi: 10.1254/jjp.52.621.
7
Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
Br J Pharmacol. 1996 Jun;118(4):941-50. doi: 10.1111/j.1476-5381.1996.tb15490.x.
8
The role of thromboxane A2 (TxA2) in allergic cutaneous reactions and the effect of (E)-3-[p-(1H-imidazol-1-ylmethyl) phenyl]-2-propenoic acid hydrochloride (OKY-046), a TxA2 synthetase inhibitor.血栓素A2(TxA2)在过敏性皮肤反应中的作用以及TxA2合成酶抑制剂盐酸(E)-3-[对-(1H-咪唑-1-基甲基)苯基]-2-丙烯酸(OKY-046)的作用。
Prostaglandins Leukot Essent Fatty Acids. 1989 Mar;35(3):125-30. doi: 10.1016/0952-3278(89)90112-9.
9
Pulmonary vascular responses to thromboxane A2 as unmasked by OKY-1581. A novel inhibitor of thromboxane synthesis.OKY-1581所揭示的肺血管对血栓素A2的反应。一种新型血栓素合成抑制剂。
Chest. 1983 May;83(5 Suppl):72S-74S.
10
Putative mechanism of hypotensive action of platelet-activating factor in dogs.血小板活化因子对犬降压作用的推测机制。
Circ Res. 1992 May;70(5):893-901. doi: 10.1161/01.res.70.5.893.

引用本文的文献

1
Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.一氧化氮(NO)对血小板活化因子(PAF)诱导的心肺作用的调节:NO合酶与环氧化酶-2途径之间的相互作用。
Br J Pharmacol. 2001 Oct;134(4):777-88. doi: 10.1038/sj.bjp.0704311.
2
Possible involvement of endothelium-derived hyperpolarizing factor (EDHF) in the depressor responses to platelet activating factor (PAF) in rats.内皮衍生超极化因子(EDHF)可能参与大鼠对血小板活化因子(PAF)的降压反应。
Br J Pharmacol. 2000 Nov;131(6):1113-20. doi: 10.1038/sj.bjp.0703681.
3
Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
Br J Pharmacol. 1996 Jun;118(4):941-50. doi: 10.1111/j.1476-5381.1996.tb15490.x.
4
Inhibition of PAF-acether effects on isolated guinea pig hearts by zinc ions (Zn2+).锌离子(Zn2+)对血小板活化因子(PAF-乙酰醚)作用于离体豚鼠心脏的抑制作用。
Biol Trace Elem Res. 1995 Oct;50(1):43-55. doi: 10.1007/BF02789148.
5
Effects of PAF on cardiac function and eicosanoid release in the isolated perfused rat heart: comparison between normotensive and spontaneously hypertensive rats.血小板活化因子对离体灌注大鼠心脏心功能和类花生酸释放的影响:正常血压大鼠与自发性高血压大鼠的比较
Basic Res Cardiol. 1995 Jul-Aug;90(4):337-47. doi: 10.1007/BF00797912.
6
Platelet-activating factor causes ventilation-perfusion mismatch in humans.血小板活化因子可导致人体通气-灌注不匹配。
J Clin Invest. 1994 Jan;93(1):188-94. doi: 10.1172/JCI116944.
7
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.氧自由基会抑制人体血浆乙酰水解酶,该酶可分解血小板活化因子。
J Clin Invest. 1994 Jun;93(6):2408-16. doi: 10.1172/JCI117248.
8
Ipratropium bromide protects against bronchoconstriction during bronchoscopy.
Lung. 1994;172(5):293-8. doi: 10.1007/BF00164311.
9
Mechanisms of pulmonary vasoconstriction and bronchoconstriction produced by PAF in the guinea-pig: role of platelets and cyclo-oxygenase metabolites.血小板激活因子(PAF)引起豚鼠肺血管收缩和支气管收缩的机制:血小板和环氧化酶代谢产物的作用
Br J Pharmacol. 1995 Jan;114(1):203-9. doi: 10.1111/j.1476-5381.1995.tb14926.x.
10
Cardiovascular effects of platelet-activating factor.血小板活化因子的心血管效应
Lipids. 1991 Dec;26(12):1250-6. doi: 10.1007/BF02536542.